| Title |
A Review of Dementia with Lewy Bodies' Impact, Diagnostic Criteria and Treatment
|
|---|---|
| Published in |
Neurology and Therapy, July 2018
|
| DOI | 10.1007/s40120-018-0104-1 |
| Pubmed ID | |
| Authors |
Samuel D. Capouch, Martin R. Farlow, Jared R. Brosch |
| Abstract |
Dementia with Lewy bodies is one of the most common causes of dementia. It is not as common as Alzheimer's disease; the general public's awareness of the disease is poor in comparison. Its effects on caregivers and patients alike are not well known to the general population. There are currently no FDA-approved medications specifically for the treatment of DLB. Many of the medications that are approved for Alzheimer's disease are widely used in the treatment of DLB with varying degrees of success. Treatment of DLB is life long and requires a dedicated team of physicians and caregivers to minimize the degree of morbidity and mortality experienced by the patients suffering from the disease as it progresses. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 25% |
| Unknown | 3 | 75% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 50% |
| Science communicators (journalists, bloggers, editors) | 2 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 114 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 114 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 22 | 19% |
| Student > Ph. D. Student | 14 | 12% |
| Other | 10 | 9% |
| Student > Master | 10 | 9% |
| Researcher | 9 | 8% |
| Other | 19 | 17% |
| Unknown | 30 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 27 | 24% |
| Neuroscience | 17 | 15% |
| Biochemistry, Genetics and Molecular Biology | 7 | 6% |
| Nursing and Health Professions | 6 | 5% |
| Psychology | 5 | 4% |
| Other | 13 | 11% |
| Unknown | 39 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 July 2018.
All research outputs
#3,162,862
of 25,994,718 outputs
Outputs from Neurology and Therapy
#97
of 575 outputs
Outputs of similar age
#59,079
of 342,176 outputs
Outputs of similar age from Neurology and Therapy
#4
of 7 outputs
Altmetric has tracked 25,994,718 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 575 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 16.3. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 342,176 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.